Caris Life Sciences and Flatiron Health Partner to Vastly Increase Access to Most Comprehensive Molecular Testing Available Irving, Business
Vizient Presents Clinical Performance, Supply Chain Awards at the 2022 Connections Summit Irving, Business
The Crafty Cask Launches the First Rotating Alcohol Subscription Box for Craft Drink Explorers Irving
Caris Life Sciences to Present Novel Research Findings with Leading Cancer Centers Reflecting Its Commitment to Improving Patient Outcomes and Care at ESMO 2022 Irving, Business
Vizient Medical Device Tech Watch Highlights Trends in AI, Treatment Options for Pulmonary Embolism and Strategies to Boost Clinical Workforce Retention Irving, Business
Nexstar Media Charitable Foundation Donates $50,000 to Feeding America® to Commemorate September as "Hunger Action Month" Irving, Business
New Survey from Vizient Provides Hospital Insights into Biosimilar Adoption and What is Preventing Greater Utilization Irving, Business
Drop it Like it's Haute: 7-Eleven Releases Limited-Edition Apparel Collection with Overtime and Easy Otabor Irving, Business
The Council for Inclusion in Financial Services to Salute Brands Committed to Industry-Wide Diversity, Equity and Inclusion Irving, Real Estate, Financial
Caris Life Sciences and Xencor Enter Target Discovery Collaboration and License Agreement for Novel XmAb® Bispecific Antibodies Irving, Business
Vizient Acquires Safe & Reliable Healthcare, Creates New Streamlined Solution for Sustained Delivery of Safe Healthcare Irving, Business
Vizient Announces Strategic Partnership with Mpirik to Improve Care, Health Equity in Cardiology with Help From AI Irving, Business
Caris Life Sciences Announces Appointment of Russ Denton as General Counsel
7-Eleven Debuts New Online Merchandise Store, 7Collection
Drop it Like it's Haute: 7-Eleven Releases Limited-Edition Apparel Collection with Overtime and Easy Otabor
The Council for Inclusion in Financial Services to Salute Brands Committed to Industry-Wide Diversity, Equity and Inclusion
Caris Life Sciences and Xencor Enter Target Discovery Collaboration and License Agreement for Novel XmAb® Bispecific Antibodies